Vidyya Medical News Service
*
Volume 5 Issue 162 Published - 14:00 UTC 08:00 EST 11-June-2003 Next Update - 14:00 UTC 08:00 EST 12-June-2003
little clear gif used for spacer
.
*

Aspirin as effective as Ticlopidine in African American antiplatelet stroke prevention study
Results from the African American Antiplatelet Stroke Prevention Study (AAASPS), a large multicenter trial of 1,809 African American stroke patients from over 60 sites in the United States, show that aspirin is as effective as ticlopidine for prevention of a second stroke in this population. The study, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) is published in the June 11, 2003, issue of the Journal of the American Medical Association.  more

*
American Heart Association report: Fewer neurological complications seen with off-pump coronary bypass surgery
Patients undergoing coronary bypass surgery may have fewer neurological complications after surgery if a pump supporting the heart and lungs is not used, researchers say in a report, presented at the American Heart Association's Second Asia Pacific Scientific Forum.  more

 


*
Triple-drug therapy does not appear to raise cholesterol levels in men with HIV
Treatment with highly active antiretroviral therapy (HAART), commonly known as triple-drug therapy, does not appear to raise cholesterol levels in men with human immunodeficiency virus (HIV), according to researchers at the University of Pittsburgh. These findings, published in the June 11 issue of the Journal of the American Medical Association, help to clarify a controversial issue that has been debated since the advent of HAART seven years ago.  more

*
Researchers identify biological basis for improvement in prognosis of AIDS-related lymphoma patients
Since the use of highly active antiretroviral therapy (HAART) to treat HIV, physicians have seen an improvement in the prognosis for patients with AIDS-related lymphomas. Researchers from the National Cancer Institute (NCI) have now identified a biological basis for this change. The results of the new study, reported in the June 15, 2003, issue of the journal Blood*, suggest that the use of HAART has caused a shift in the majority of AIDS-related lymphomas to a type that usually responds well to chemotherapy.  more

*
SARS update - WHO officials to visit China
Dr David Heymann, Executive Director for Communicable Diseases at WHO, is travelling to China, where he will confer with health officials about the SARS outbreak and discuss plans for the future. Other members of the team include Dr Gunal Rodier, Director of Communicable Disease Surveillance and Response, and Dr Thomas Grein, who coordinates global response operations for SARS.  more

 
little clear gif used for a space